You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 20, 2025

Details for Patent: 11,154,509


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,154,509
Title:Methods for controlled release oral dosage of a vitamin D compound
Abstract: A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.
Inventor(s): Bishop; Charles W. (Miami Beach, FL), Tabash; Samir P. (Whitby, CA), Agudoawu; Sammy A. (Mississauga, CA), White; Jay A. (Newmarket, CA), Crawford; Keith H. (Lone Tree, CO), Messner; Eric J. (Lake Forest, IL), Petkovich; P. Martin (Kingston, CA)
Assignee: EIRGEN PHARMA LTD. (Waterford, IE) OPKO RENAL, LLC (Miami, FL)
Application Number:15/726,046
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide

Understanding the Importance of Patent Analysis

Patent analysis is a crucial step in the innovation and intellectual property protection process. It helps inventors, researchers, and businesses understand the existing patent landscape, avoid infringement, and identify potential opportunities for innovation. Here, we will delve into the specifics of analyzing the scope and claims of a U.S. patent, using the example of U.S. Patent 11,154,509.

Identifying the Patent

To begin, you need to identify the patent in question. For U.S. Patent 11,154,509, you can use the USPTO's Patent Public Search tool or other patent databases such as those provided by the European Patent Office (EPO) or the World Intellectual Property Organization (WIPO)[1][4].

Accessing Patent Documents

You can access the full text of the patent through the USPTO's Patent Public Search tool. This tool replaced older search tools like PubEast and PubWest and provides enhanced access to prior art[1].

Reading the Patent Specification

The patent specification includes a detailed description of the invention, drawings, and claims. Here’s how to analyze each part:

Description and Drawings

  • The description section provides a detailed explanation of the invention, including its background, summary, and detailed description.
  • Drawings are visual representations of the invention and can be crucial in understanding the invention's structure and functionality.

Claims

  • The claims section is the most critical part of the patent as it defines the scope of the invention. Claims are statements that define the invention and distinguish it from prior art.
  • There are two types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Analyzing the Claims of U.S. Patent 11,154,509

Claim Structure

  • Start by identifying the independent claims, as these define the broadest scope of the invention.
  • Dependent claims will further narrow down the invention, often adding specific details or limitations.

Claim Language

  • Pay close attention to the language used in the claims. Words like "comprising," "consisting of," and "including" can have significant implications on the scope of the invention.
  • Understand the relationships between claims, especially how dependent claims modify the independent claims.

Claim Scope

  • Determine the breadth of the claims. Are they narrowly defined or broadly encompassing?
  • Identify any limitations or exceptions within the claims that could affect the patent's scope.

Understanding the Patent Landscape

Prior Art

  • Use tools like the Common Citation Document (CCD) to see the prior art cited by various patent offices for the same invention. This helps in understanding how the patent office viewed the novelty and non-obviousness of the invention[1].
  • Search international patent databases to see if similar patents exist in other jurisdictions.

Patent Family

  • Utilize the Global Dossier service to view the patent family for the specific application. This includes all related applications filed at participating IP Offices, along with dossier, classification, and citation data[1].

Tools and Resources for Patent Analysis

USPTO Resources

  • The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer trained staff and resources to assist in patent searching and analysis[1].
  • The Patent Examination Data System (PEDS) allows users to search, view, and download bibliographic data for publicly available patent applications[1].

International Resources

  • Databases like esp@cenet from the EPO, PATENTSCOPE from WIPO, and other international patent offices provide access to global patent collections[1][4].

Statistical Analysis and Trends

Patent Claims Research Dataset

  • The USPTO's Patent Claims Research Dataset can provide insights into claim-level statistics and document-level statistics, including measures of patent scope. This dataset covers U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014[3].

Practical Considerations

Legal and Policy Implications

  • Understanding the legal and policy considerations is crucial. For instance, the concept of a small claims patent court, as studied by ACUS, could impact how patent disputes are resolved[2].

Economic Impact

  • Analyze the economic implications of the patent. How does it fit into the broader market? What are the potential economic benefits or barriers?

Example: Analyzing U.S. Patent 11,154,509

Step-by-Step Analysis

  • Identify the Patent: Search for U.S. Patent 11,154,509 using the USPTO's Patent Public Search tool.
  • Read the Specification: Review the description, drawings, and claims to understand the invention.
  • Analyze Claims: Identify independent and dependent claims, and analyze their language and scope.
  • Check Prior Art: Use the CCD and other tools to see the prior art cited for this invention.
  • Global Landscape: Use the Global Dossier to view related applications in other jurisdictions.

Highlight: Importance of Claim Language

"The claims of a patent define the scope of the invention and are thus the most critical part of the patent. The language used in the claims can significantly affect the scope of protection afforded by the patent"[3].

Key Takeaways

  • Detailed Specification: The patent specification provides a comprehensive description of the invention.
  • Claims Analysis: Understanding the claims is crucial for determining the patent's scope.
  • Prior Art and Global Landscape: Analyzing prior art and the global patent family helps in understanding the invention's novelty and non-obviousness.
  • Tools and Resources: Utilize USPTO resources, international databases, and statistical datasets to enhance your analysis.
  • Legal and Economic Considerations: Consider the legal and economic implications of the patent.

FAQs

Q: How do I access the full text of a U.S. patent?

A: You can access the full text of a U.S. patent using the USPTO's Patent Public Search tool or other patent databases like those provided by the EPO or WIPO.

Q: What is the difference between independent and dependent claims?

A: Independent claims define the invention broadly, while dependent claims further narrow down the invention by adding specific details or limitations.

Q: How can I check if a similar patent exists in other countries?

A: Use the Global Dossier service or search international patent databases such as esp@cenet or PATENTSCOPE.

Q: What is the Common Citation Document (CCD)?

A: The CCD provides a single point of access to citation data relating to the patent applications of the IP5 Offices, consolidating prior art cited by all participating offices.

Q: Where can I find training resources for patent searching?

A: The USPTO provides training materials and tutorials, and you can also visit a Patent and Trademark Resource Center (PTRC) for assistance.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,154,509

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eirgen RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 11,154,509 ⤷  Try for Free TREATING SECONDARY HYPERPARATHYROIDISM IN STAGE 3 OR 4 CKD WITH SUSTAINED RELEASE 25-HYDROXYVITAMIN D TO REDUCE THE PATIENT'S SERUM PARATHYROID HORMONE LEVEL WHILE AVOIDING PTH OVERSUPPRESSION ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,154,509

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2481400 ⤷  Try for Free 301085 Netherlands ⤷  Try for Free
European Patent Office 2481400 ⤷  Try for Free 122020000079 Germany ⤷  Try for Free
European Patent Office 2481400 ⤷  Try for Free CA 2020 00059 Denmark ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.